FUNDING CALLS

Current funding opportunities

Open funding calls with no closing date can be found on a separate page below

Invention for Innovation – Connect 8

National Institute for Health and Care Research (NIHR)

21 February 2024
£150,000
12 months

The NIHR Invention for Innovation (i4i) programme invites proposals to Call 8 of its researcher-led Connect. i4i Connect helps SMEs in need of a funding boost get to the next stage in the developmental pathway and accelerate the development of promising medical technologies e.g. get to the point where they can apply for further funding, such as an i4i Product Development Award, or to support projects at any stage of the translational research and development pathway to further de-risk them for follow on investment.

Action Medical Research Project Grant in Child Health

Action Medical Research

27 February 2024
£200,000
3 years

Applications are invited across the breadth of Action’s remit, to prevent and treat disease and disability by funding vital medical research in hospitals or research institutions across the UK. The remit focuses on child health to include problems affecting pregnancy, childbirth, babies, children and young people.

Innovate UK Investor Partnerships: SME Round 6

Innovate UK

27 February 2024
Depends on research category
Depends on research category

Innovate UK, as part of UK Research and Innovation, has selected a pool of investor partners. These investor partners have demonstrated that they have the credibility, capability, capacity and appetite to invest in innovative, technology-led businesses that align with Innovate UK programmes.

The aim of this competition is to provide you with support for research and development and access to the capital investment you need to develop and commercialise your innovations.

Developmental Pathway Funding Scheme: Invite Stage Two

Medical Research Council (MRC)

6 March 2024
No limit
No limit

Apply for funding for an academically-led translational project that aims to improve prevention, diagnosis or treatment of significant health needs or develop research tools that increase the efficiency of developing interventions. You can apply for funding for work that includes, but is not limited to, novel medical devices, digital healthcare, app development, artificial intelligence, diagnostics, medical imaging technology, and surgical techniques or tools.

Funding for early stage development of new healthcare interventions

Medical Research Council (MRC)

13 March 2024
£300,000
2 years

Apply for funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development. The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product.

Knowledge Asset Grant Fund: Explore, Expand and Extend Spring 2024

Innovate UK

14 March 2024
See below
See below

The Knowledge Asset Grant Fund (KAGF) is run by the Government Office for Technology Transfer (GOTT) and funded by the Department for Science Innovation and Technology (DSIT). The aim of this competition is to support the identification and development of public sector knowledge assets, including repurposing, commercialisation or expanded use. These assets can include inventions, data & information, designs, expertise, business processes and other intellectual resources.

This competition is split into 3 strands:

  • Explore – for projects up to £25,000
  • Expand – for projects between £25,001 to £100,000
  • Extend – for projects between £100,001 to £250,000

BBSRC Innovation to Commercialisation of University Research (ICURe) Explore

Biotechnology and Biological Sciences Research Council (BBSRC)

19 March 2024
£35,000
3 months

BBSRC ICURe Explore trains, funds, and supports research teams to determine whether there is a market for products or services that utilise their bioscience-based ideas, research, science, and technologies. Funding is available to ‘get out of the lab’ and validate commercially promising ideas in the marketplace. Applications are welcomed from areas including healthy ageing, engineering biology, industrial biotechnology and innovative tools and technologies.

Public Health Intervention Development (PHIND)

Medical Research Council (MRC)

19 March 2024
£150,000
18 months

MRC is looking to support the early-stage development of interventions that seek to address either UK or global public health challenges. This might include qualitative and quantitative primary research and the development of theory and logic models. However, emphasis should be placed on developing the intervention.

Developmental Pathway Funding Scheme: Stage One

Medical Research Council (MRC)

20 March 2024
No limit
No limit

Apply for funding for an academically-led translational project that aims to improve prevention, diagnosis or treatment of significant health needs or develop research tools that increase the efficiency of developing interventions. You can apply for funding for work that includes, but is not limited to, novel medical devices, digital healthcare, app development, artificial intelligence, diagnostics, medical imaging technology, and surgical techniques or tools.

2023 NIHR Team Science Award Round 1 – Multiple Long Term Conditions

National Institute for Health and Care Research (NIHR)

21 March 2024
£100,000
2 years

The NIHR Team Science Award is a development award, designed to support interdisciplinary research teams to address a research challenge from different disciplinary perspectives. The team will collaborate on a future application to other research programmes, (see Annex A), expand their research network and develop capacity in the Multiple Long-Term Conditions (Multimorbidity) (MLTC-M) field by:

  • supporting pilot research
  • funding training and development for the research team
  • establish new collaborations

AHRC Responsive Mode: Standard Research Grant – Round Three

Arts and Humanities Research Council (AHRC)

26 March 2024
£1.5 million
5 years

Arts and Humanities Research Council (AHRC) standard research grants support collaborative research projects that require leadership from more than one researcher. You must include a project lead and at least one project co-lead jointly involved in the development and management of the project and co-authored research outputs.

AHRC Responsive Mode: Follow-on funding for impact and engagement – Round Three

Arts and Humanities Research Council (AHRC)

26 March 2024
£100,000
12 months

Follow-on funding supports unforeseen knowledge exchange, public engagement, active dissemination and commercialisation activities that arise during the lifespan of, or following, an AHRC-funded project. Arts and Humanities Research Council (AHRC) funds grants of up to £100,000 for a maximum of one year, and smaller grants of up to £30,000 for shorter or higher-risk activities.

NIHR i4i & OLS Real World Evidence Programme

National Institute for Health and Care Research (NIHR)

27 March 2024
No limit
3 years

The aim of this call is to support consortia to address real world evidence gaps to accelerate widespread adoption of technologies recommended for early use in the NHS through NICE Early Value Assessment (EVA). Funding will be deployed to generate real world evidence for product(s) to achieve a full NICE evaluation, generate further evidence required by commissioners to increase uptake, and to capture generalisable learnings to support future innovators.

BBSRC Follow-On Fund: 2024 Round 1

Biotechnology and Biological Sciences Research Council (BBSRC)

27 March 2024
£800,000
2 years

Apply for follow on funding (FoF) to bridge the gap between bioscience research and achieving commercial, economic and societal benefit.

23/153 Janus kinase inhibitors for the treatment of juvenile idiopathic arthritis

National Institute for Health and Care Research (NIHR)

28 March 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

23/155 Repetitive Transcranial Magnetic Stimulation for depression in adolescents

National Institute for Health and Care Research (NIHR)

28 March 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

23/164 Adjunct corticosteroids for infant (under 3 months old) bacterial meningitis

National Institute for Health and Care Research (NIHR)

28 March 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

23/165 What are the social and mental wellbeing benefits of intergenerational practices in care homes and schools?

National Institute for Health and Care Research (NIHR)

28 March 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

23/162 Therapies for women, children and others who experience domestic abuse

National Institute for Health and Care Research (NIHR)

28 March 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

UK Japan Engineering Biology for Novel Therapies and Diagnostics Research Collaboration

Medical Research Council (MRC)

16 April 2024
Not stated
3 years

This funding opportunity aims to support ‘cutting edge’ fundamental or translational research projects by delivering joint funding for innovative collaborations between researchers from Japan and the UK in the field of engineering biology for novel therapies and diagnostics.

Japan-UK Engineering Biology for Discovery Research and Cross-Cutting Technologies

Biotechnology and Biological Sciences Research Council (BBSRC)

16 April 2024
£1 million
3 years

Based on the implementation principles of the ASPIRE program in Japan and the ISPF in the UK, this partnership program aims to support internationally competitive collaborative research projects between Japan and the UK focusing on the fundamentals of engineering biology and cross-cutting technologies, creating leading international researcher networks, and nurturing early career researchers to drive tomorrow’s engineering biology.

Experimental Medicine Stage One

Medical Research Council (MRC)

17 April 2024
No limit
No limit

Apply for funding to investigate the causes, progression and treatment of human disease. Successful projects will produce new mechanistic insights including those that may identify opportunities to modify disease pathways or enable the future development of novel therapeutic or diagnostic approaches.

23/170 EME Platform studies to efficiently evaluate the efficacy of multiple interventions

National Institute for Health and Care Research (NIHR)

23 April 2024
Not stated
Not stated

The Efficacy and Mechanism Evaluation (EME) Programme is accepting Stage 1 applications to their commissioned workstream. The EME Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.

23/144 Healthy homes

National Institute for Health and Care Research (NIHR)

23 April 2024
Not stated
Not stated

The Public Health Research (PHR) Programme funds research to generate evidence to inform the delivery of non-NHS interventions, intended to improve the health of the public, and reduce inequalities in health. The PHR Programme is accepting applications to the commissioned workstream to explore the health and health inequality impacts of interventions affecting the physical quality of UK housing.

23/171 Efficacy and Mechanism Evaluation Programme Researcher-led

National Institute for Health and Care Research (NIHR)

23 April 2024
Not stated
Not stated

The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.

23/173 NIHR NICE Rolling Call (EME Programme)

National Institute for Health and Care Research (NIHR)

23 April 2024
Not stated
Not stated

The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.

The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015.

23/172 NIHR James Lind Alliance Priority Setting Partnerships Rolling Call (EME Programme)

National Institute for Health and Care Research (NIHR)

23 April 2024
Not stated
Not stated

The Efficacy and Mechanism Evaluation (EME) Programme supports translational research evaluating a wide range of novel or repurposed interventions and technologies. These may include but are not limited to diagnostic or prognostic tests and decision-making tools, drugs or biological compounds, behavioural therapies, medical devices, and public health initiatives delivered within the NHS.

The programme recognises the importance of the research priorities identified by the James Lind Alliance (JLA) Priority Setting Partnerships (PSP) and are interested in receiving high-quality applications for research studies which aim to address them, rather than to conduct a PSP itself.

Smart Grants: Jan 2024

Innovate UK

24 April 2024
See below
See below

The Innovate UK Smart grant has focused scope and eligibility criteria to support SMEs and their partners develop disruptive innovations with significant potential for rapid economic return to the UK. The application process reflects the importance of obtaining economic benefits from public funding, and the potential for successful commercialisation, growth, and exports.

  • Projects with a duration of 6 to 18 months must have total eligible project costs between £100,000 and £500,000.
  • Projects with a duration of 19 to 24 months must have total eligible project costs between £100,000 and £1 million.

AHRC Responsive Mode: Curiosity Award Round Three

Arts and Humanities Research Council (AHRC)

30 April 2024
£100,000
5 years

Curiosity awards support early-stage ambitious and novel fundamental research which has the potential to act as a springboard towards new and exciting research agendas. The funding opportunity celebrates the full diversity of the arts and humanities. It is flexible, and applications are welcomed from teams, networks, and solo researchers.

AHRC Responsive Mode: Catalyst Award Round Three

Arts and Humanities Research Council (AHRC)

30 April 2024
£300,000
5 years

Catalyst awards support researchers without prior experience of leading a significant research project to accelerate their trajectory as independent researchers, unlocking their potential and building leadership and convenor experience through the delivery of ambitious or complex projects.

24/2 Health Technology Assessment Programme Researcher-led (24/1 primary research, 24/2 evidence synthesis)

National Institute for Health and Care Research (NIHR)

1 May 2024
Not stated
Not stated

The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services. In this researcher-led workstream, separate grants are available for primary research and evidence synthesis on topics proposed by the researchers.

24/3 NIHR NICE Rolling Call (HTA Programme)

National Institute for Health and Care Research (NIHR)

1 May 2024
Not stated
Not stated

The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

The programme is interested in receiving Stage 1 applications to meet recommendations in research identified in NICE guidance that has been published or updated since 2015.

24/4 NIHR James Lind Alliance Priority Setting Partnerships Rolling Call (HTA Programme)

National Institute for Health and Care Research (NIHR)

1 May 2024
Not stated
Not stated

The aim of the Health Technology Assessment (HTA) Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

The NIHR are looking to receive applications for research studies addressing JLA PSPs’ research priorities, rather than to conduct a PSP itself.

UK – Switzerland Collaborative Research and Development: Round 2

Innovate UK

1 May 2024
£450,000
3 years

The aim of this competition is to enhance UK and Swiss collaborations and capabilities in the emerging fields of technology. The result being, the developing and delivering of new innovations and applications of the technologies across a broad range of other sectors.

23/152 Clinical prediction models for early-onset neonatal infection

National Institute for Health and Care Research (NIHR)

22 May 2024
Not stated
Not stated

The Health Technology Assessment (HTA) Programme is accepting applications to their commissioned workstream. The aim of HTA Programme is to ensure that high quality research information on the clinical effectiveness, cost-effectiveness and broader impact of healthcare treatments and tests are produced in the most efficient way for those who plan, provide or receive care from NHS and social care services.

UK – Germany Bilateral: Collaboration R&D Round 3

Innovate UK

3 June 2024
£500,000
3 years

The aim of this competition is to enhance UK and German collaborations and capabilities in the emerging fields of technology in our society. This is to develop and deliver new innovations and applications of the technologies across a broad range of sectors.

Develop Guidance for Better Research Methods

Medical Research Council (MRC) – National Institute for Health and Care Research (NIHR)

12 June 2024
£60,000
18 months

Apply for funding to develop new guidance on biomedical and health research methods. This funding opportunity will support the development of guidance in priority areas of methodological uncertainty, with the aim of catalysing uptake of improved research methods.

PRP (38-01-04) Medical devices in pregnancy and neonatal period

National Institute for Health and Care Research (NIHR)

18 June 2024
£500,000
2 years

The National Institute for Health and Care Research (NIHR) Policy Research Programme (PRP) invites applications for a single research project to explore Equity in Medical Devices during the Pregnancy and Neonatal Period. This research is needed to assess whether there are disparities in the medical devices used during the pregnancy and neonatal period which are contributing to the disparities in maternal and neonatal outcomes. The research is also needed to understand how medical devices could be adapted to ensure equity in maternity and neonatal care.

EPSRC Programme Grant Outline Stage January 2024

Engineering and Physical Sciences Research Council (EPSRC)

25 June 2024
Not stated
2 years

Programme grants provide flexible funding to world-leading research groups seeking to address significant research challenges across the EPSRC remit. We expect most successful applications to be interdisciplinary and collaborative, but they can also address key challenges in a single discipline. They are not just large grants, they must be strategic in nature.

Reducing Compound Pressures on the NHS and Social Care

National Institute for Health and Care Research (NIHR)

26 June 2024
See below
See below

The NIHR wants to generate high-quality research evidence into the evaluation of health and care interventions and services, to reduce compound pressures on the NHS and social care. This cross-programme call for research supports the recently published Department of Health and Social Care Areas of Research Interest, which calls for high quality evidence to support those who plan, commission, manage, deliver and use services across the health, public health and social care sector.

The NIHR programmes participating in this call for research that are still open for applications and their respective closing dates dates are:

  • NIHR Academy (opening April 2024)
  • Research for Patient Benefit (RfPB), 6 March 2024
  • Research Programme for Social Care (RPSC), 26 June 2024